Hundreds of people with a rare form of blood cancer could be set to benefit after NICE recommended a new targeted treatment ...
CHEERS-AI builds on existing best practice in health economic evaluation reporting by including the original 28 standards ...
Studies have showed using TriageHF reduced all-cause hospitalisations by 58% according to Ahmed et al. (2024). Using ...
Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their ...
Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...
A list of downloadable documents created during development.
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices
This guidance replaces NICE medtech innovation briefing 298 on TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart ...
Suggested remit: To appraise the clinical and cost effectiveness of efgartigimod with recombinant human hyaluronidase PH20 within its marketing authorisation for treating chronic inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback